Found 9 hits for monomerid = 50135457 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Retinoid receptor
(Homo sapiens (Human)) | BDBM50135457
![PNG](/data/jpeg/tenK5013/BindingDB_50135457.png) ((2E,4E,6E)-7-[2-(2,2-Difluoro-ethoxy)-3,5-bis-(1,1...)Show SMILES CCC(C)(C)c1cc(\C(C)=C(\F)/C=C/C(/C)=C/C(O)=O)c(OCC(F)F)c(c1)C(C)(C)CC Show InChI InChI=1S/C27H37F3O3/c1-9-26(5,6)19-14-20(18(4)22(28)12-11-17(3)13-24(31)32)25(33-16-23(29)30)21(15-19)27(7,8)10-2/h11-15,23H,9-10,16H2,1-8H3,(H,31,32)/b12-11+,17-13+,22-18+ | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| 5.20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ligand Pharmaceuticals Inc
Curated by ChEMBL
| Assay Description Displacement of [3H]-9-cis-RA from RXR beta receptor in CV-1 cells |
Bioorg Med Chem Lett 13: 4071-5 (2003)
BindingDB Entry DOI: 10.7270/Q2V987GP |
More data for this Ligand-Target Pair | |
Retinoic acid receptor RXR-alpha
(Homo sapiens (Human)) | BDBM50135457
![PNG](/data/jpeg/tenK5013/BindingDB_50135457.png) ((2E,4E,6E)-7-[2-(2,2-Difluoro-ethoxy)-3,5-bis-(1,1...)Show SMILES CCC(C)(C)c1cc(\C(C)=C(\F)/C=C/C(/C)=C/C(O)=O)c(OCC(F)F)c(c1)C(C)(C)CC Show InChI InChI=1S/C27H37F3O3/c1-9-26(5,6)19-14-20(18(4)22(28)12-11-17(3)13-24(31)32)25(33-16-23(29)30)21(15-19)27(7,8)10-2/h11-15,23H,9-10,16H2,1-8H3,(H,31,32)/b12-11+,17-13+,22-18+ | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| 29 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ligand Pharmaceuticals Inc
Curated by ChEMBL
| Assay Description Binding affinity against RXR alpha receptor using [3H]-9-cis-RA as radioligand in CV-1 cells |
Bioorg Med Chem Lett 13: 4071-5 (2003)
BindingDB Entry DOI: 10.7270/Q2V987GP |
More data for this Ligand-Target Pair | |
Retinoid X receptor gamma/retinoic acid receptor alpha
(Homo sapiens (Human)) | BDBM50135457
![PNG](/data/jpeg/tenK5013/BindingDB_50135457.png) ((2E,4E,6E)-7-[2-(2,2-Difluoro-ethoxy)-3,5-bis-(1,1...)Show SMILES CCC(C)(C)c1cc(\C(C)=C(\F)/C=C/C(/C)=C/C(O)=O)c(OCC(F)F)c(c1)C(C)(C)CC Show InChI InChI=1S/C27H37F3O3/c1-9-26(5,6)19-14-20(18(4)22(28)12-11-17(3)13-24(31)32)25(33-16-23(29)30)21(15-19)27(7,8)10-2/h11-15,23H,9-10,16H2,1-8H3,(H,31,32)/b12-11+,17-13+,22-18+ | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| 40 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ligand Pharmaceuticals Inc
Curated by ChEMBL
| Assay Description Binding affinity against RXR gamma receptor using [3H]-9-cis-RA as radioligand in CV-1 cells |
Bioorg Med Chem Lett 13: 4071-5 (2003)
BindingDB Entry DOI: 10.7270/Q2V987GP |
More data for this Ligand-Target Pair | |
Retinoid receptor
(Homo sapiens (Human)) | BDBM50135457
![PNG](/data/jpeg/tenK5013/BindingDB_50135457.png) ((2E,4E,6E)-7-[2-(2,2-Difluoro-ethoxy)-3,5-bis-(1,1...)Show SMILES CCC(C)(C)c1cc(\C(C)=C(\F)/C=C/C(/C)=C/C(O)=O)c(OCC(F)F)c(c1)C(C)(C)CC Show InChI InChI=1S/C27H37F3O3/c1-9-26(5,6)19-14-20(18(4)22(28)12-11-17(3)13-24(31)32)25(33-16-23(29)30)21(15-19)27(7,8)10-2/h11-15,23H,9-10,16H2,1-8H3,(H,31,32)/b12-11+,17-13+,22-18+ | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| 5.33E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ligand Pharmaceuticals Inc
Curated by ChEMBL
| Assay Description Binding affinity against RAR beta receptor using [3H]-ATRA as radioligand in CV-1 cells |
Bioorg Med Chem Lett 13: 4071-5 (2003)
BindingDB Entry DOI: 10.7270/Q2V987GP |
More data for this Ligand-Target Pair | |
Retinoid X receptor gamma/retinoic acid receptor alpha
(Homo sapiens (Human)) | BDBM50135457
![PNG](/data/jpeg/tenK5013/BindingDB_50135457.png) ((2E,4E,6E)-7-[2-(2,2-Difluoro-ethoxy)-3,5-bis-(1,1...)Show SMILES CCC(C)(C)c1cc(\C(C)=C(\F)/C=C/C(/C)=C/C(O)=O)c(OCC(F)F)c(c1)C(C)(C)CC Show InChI InChI=1S/C27H37F3O3/c1-9-26(5,6)19-14-20(18(4)22(28)12-11-17(3)13-24(31)32)25(33-16-23(29)30)21(15-19)27(7,8)10-2/h11-15,23H,9-10,16H2,1-8H3,(H,31,32)/b12-11+,17-13+,22-18+ | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| 6.59E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ligand Pharmaceuticals Inc
Curated by ChEMBL
| Assay Description Binding affinity against RAR alpha receptor using [3H]-ATRA as radioligand in CV-1 cells |
Bioorg Med Chem Lett 13: 4071-5 (2003)
BindingDB Entry DOI: 10.7270/Q2V987GP |
More data for this Ligand-Target Pair | |
Retinoid receptor
(Homo sapiens (Human)) | BDBM50135457
![PNG](/data/jpeg/tenK5013/BindingDB_50135457.png) ((2E,4E,6E)-7-[2-(2,2-Difluoro-ethoxy)-3,5-bis-(1,1...)Show SMILES CCC(C)(C)c1cc(\C(C)=C(\F)/C=C/C(/C)=C/C(O)=O)c(OCC(F)F)c(c1)C(C)(C)CC Show InChI InChI=1S/C27H37F3O3/c1-9-26(5,6)19-14-20(18(4)22(28)12-11-17(3)13-24(31)32)25(33-16-23(29)30)21(15-19)27(7,8)10-2/h11-15,23H,9-10,16H2,1-8H3,(H,31,32)/b12-11+,17-13+,22-18+ | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ligand Pharmaceuticals Inc
Curated by ChEMBL
| Assay Description Binding affinity against RAR gamma receptor using [3H]-ATRA as radioligand in CV-1 cells |
Bioorg Med Chem Lett 13: 4071-5 (2003)
BindingDB Entry DOI: 10.7270/Q2V987GP |
More data for this Ligand-Target Pair | |
Retinoic acid receptor RXR-alpha
(Homo sapiens (Human)) | BDBM50135457
![PNG](/data/jpeg/tenK5013/BindingDB_50135457.png) ((2E,4E,6E)-7-[2-(2,2-Difluoro-ethoxy)-3,5-bis-(1,1...)Show SMILES CCC(C)(C)c1cc(\C(C)=C(\F)/C=C/C(/C)=C/C(O)=O)c(OCC(F)F)c(c1)C(C)(C)CC Show InChI InChI=1S/C27H37F3O3/c1-9-26(5,6)19-14-20(18(4)22(28)12-11-17(3)13-24(31)32)25(33-16-23(29)30)21(15-19)27(7,8)10-2/h11-15,23H,9-10,16H2,1-8H3,(H,31,32)/b12-11+,17-13+,22-18+ | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Ligand Pharmaceuticals Inc
Curated by ChEMBL
| Assay Description In vitro anatagonist activity against RXR alpha in CV-1 cells |
Bioorg Med Chem Lett 13: 4071-5 (2003)
BindingDB Entry DOI: 10.7270/Q2V987GP |
More data for this Ligand-Target Pair | |
Peroxisome proliferator-activated receptor
(Homo sapiens (Human)) | BDBM50135457
![PNG](/data/jpeg/tenK5013/BindingDB_50135457.png) ((2E,4E,6E)-7-[2-(2,2-Difluoro-ethoxy)-3,5-bis-(1,1...)Show SMILES CCC(C)(C)c1cc(\C(C)=C(\F)/C=C/C(/C)=C/C(O)=O)c(OCC(F)F)c(c1)C(C)(C)CC Show InChI InChI=1S/C27H37F3O3/c1-9-26(5,6)19-14-20(18(4)22(28)12-11-17(3)13-24(31)32)25(33-16-23(29)30)21(15-19)27(7,8)10-2/h11-15,23H,9-10,16H2,1-8H3,(H,31,32)/b12-11+,17-13+,22-18+ | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | n/a | n/a | 2.70 | n/a | n/a | n/a | n/a |
Ligand Pharmaceuticals Inc
Curated by ChEMBL
| Assay Description In vitro agonistic activity against PPAR gamma along with 100 nM BRL49653 |
Bioorg Med Chem Lett 13: 4071-5 (2003)
BindingDB Entry DOI: 10.7270/Q2V987GP |
More data for this Ligand-Target Pair | |
Peroxisome proliferator-activated receptor
(Homo sapiens (Human)) | BDBM50135457
![PNG](/data/jpeg/tenK5013/BindingDB_50135457.png) ((2E,4E,6E)-7-[2-(2,2-Difluoro-ethoxy)-3,5-bis-(1,1...)Show SMILES CCC(C)(C)c1cc(\C(C)=C(\F)/C=C/C(/C)=C/C(O)=O)c(OCC(F)F)c(c1)C(C)(C)CC Show InChI InChI=1S/C27H37F3O3/c1-9-26(5,6)19-14-20(18(4)22(28)12-11-17(3)13-24(31)32)25(33-16-23(29)30)21(15-19)27(7,8)10-2/h11-15,23H,9-10,16H2,1-8H3,(H,31,32)/b12-11+,17-13+,22-18+ | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | n/a | n/a | 51 | n/a | n/a | n/a | n/a |
Ligand Pharmaceuticals Inc
Curated by ChEMBL
| Assay Description In vitro agonist efficacy against PPAR gamma along with 100 nM BRL49653 |
Bioorg Med Chem Lett 13: 4071-5 (2003)
BindingDB Entry DOI: 10.7270/Q2V987GP |
More data for this Ligand-Target Pair | |